NCT04697576 2026-03-10
Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma
Ohio State University Comprehensive Cancer Center
Phase 1 Recruiting
Clinical Trials
5 trialsNCT02998736 2022-12-28
PERIOP-04
Ottawa Hospital Research Institute
Phase 1 Completed
NCT04221971 2020-10-01
NK Cell Infusion for Patients With Acute Myeloid Leukemia
Peking University People's Hospital
Phase 1 Unknown
NCT01695733 2018-08-31
Response to Influenza Vaccine in Patients With Non-Hematologic Malignancies Receiving Chemotherapy
Washington University School of Medicine
Phase 1 Terminated
NCT01941758 2018-07-05
High-Dose Trivalent Influenza Vaccine in Inducing Immune Response Patients With Central Nervous System Tumors
Wake Forest University Health Sciences
Phase 1 Completed